<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Seasonal influenza in children: Clinical features and diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Seasonal influenza in children: Clinical features and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Seasonal influenza in children: Clinical features and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Flor M Munoz, MD, MSc</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 30, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Influenza is an acute respiratory illness caused by influenza A or B viruses, and rarely influenza C viruses. It occurs in outbreaks worldwide every year, mainly during the winter seasons in temperate climates. Signs and symptoms of upper and/or lower respiratory tract involvement are common, but the presentation varies with age and previous experience with influenza virus.</p><p>Although influenza generally is an acute, self-limited, and usually uncomplicated disease in healthy children, it can be associated with severe morbidity and mortality. Certain groups of children are at increased risk of severe or complicated influenza infection  (<a class="graphic graphic_table graphicRef72029" href="/z/d/graphic/72029.html" rel="external">table 1</a>).</p><p>The clinical features and diagnosis of influenza in children will be reviewed here. The epidemiology of influenza, the prevention and treatment of influenza in children, the clinical manifestations and diagnosis of influenza in adults, and the clinical manifestations and diagnosis of avian influenza are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7006.html" rel="external">"Influenza: Epidemiology and pathogenesis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5960.html" rel="external">"Seasonal influenza in children: Prevention with vaccines"</a> and  <a class="medical medical_review" href="/z/d/html/5985.html" rel="external">"Seasonal influenza in children: Management"</a> and  <a class="medical medical_review" href="/z/d/html/132409.html" rel="external">"Seasonal influenza in children: Prevention with antiviral drugs"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7004.html" rel="external">"Seasonal influenza in adults: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7001.html" rel="external">"Avian influenza: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H167452486"><span class="h1">VIROLOGY</span><span class="headingEndMark"> — </span>Influenza infection generally is caused by influenza virus types A and B. Influenza A viruses are classified into subtypes according to two surface antigens: the hemagglutinin (HA) and neuraminidase (NA) antigens, which determine influenza nomenclature (eg, H1N1, H3N2) [<a href="#rid1">1</a>]. Influenza C viruses also may cause influenza infection, particularly in young children [<a href="#rid2">2-7</a>]. Although the prevalence of influenza C usually is lower than that of influenza A or B, influenza C epidemics may occur [<a href="#rid8">8,9</a>]. (See  <a class="medical medical_review" href="/z/d/html/7006.html" rel="external">"Influenza: Epidemiology and pathogenesis"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Influenza occurs in distinct outbreaks every year, mainly during the winter months in temperate climates, although the specific timing and duration of the influenza season vary from country to country and year to year [<a href="#rid10">10</a>]. The epidemiologic pattern reflects changes in the hemagglutinin and neuraminidase surface proteins (ie, antigenic shifts or drifts). The subsequent spread, duration, and severity of the outbreak depend upon the susceptibility of the population. (See  <a class="medical medical_review" href="/z/d/html/7006.html" rel="external">"Influenza: Epidemiology and pathogenesis"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Influenza activity</span><span class="headingEndMark"> — </span>Information about influenza activity at the national, regional, and state level is available from the United States Centers for Disease Control and Prevention () and the World Health Organization (). Surveillance information is updated regularly during influenza season. (See  <a class="medical medical_review" href="/z/d/html/5960.html" rel="external">"Seasonal influenza in children: Prevention with vaccines", section on 'Influenza activity'</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Transmission</span><span class="headingEndMark"> — </span>Influenza viruses are spread from person to person, through contact with respiratory secretions (through sneezing, coughing, talking, touching) or contaminated objects (fomites) [<a href="#rid11">11-13</a>]. However, sneezing and coughing are not necessary for transmission. Influenza also may be spread by small particle aerosols that are released into the air during breathing [<a href="#rid14">14-17</a>]. Children are important vectors for the spread of disease.</p><p>The incubation period is usually one to four days (mean two days), resulting in rapid and high transmissibility [<a href="#rid1">1</a>].</p><p>Influenza A viral shedding peaks at 24 to 48 hours of illness and then rapidly declines; little or no viral replication is detectable in the respiratory tract after 5 to 10 days [<a href="#rid18">18-21</a>]. Influenza B viral shedding appears to be bimodal, with peaks 48 hours before and 24 to 48 hours after symptom onset [<a href="#rid21">21</a>]. This means that patients can be contagious before the onset of symptoms and for several days after. Longer periods of shedding can occur in immunocompromised hosts and young children, especially those with primary infection, due to the relative lack of immunity [<a href="#rid22">22-26</a>].</p><p>The magnitude of shedding varies from patient to patient and appears to correlate with symptoms and severity of illness, particularly with influenza A [<a href="#rid14">14,19,21,27</a>]. However, even children with mild symptoms remain an important reservoir of disease given their prolonged viral shedding.</p><p class="headingAnchor" id="H6"><span class="h2">Burden of disease</span><span class="headingEndMark"> — </span>The attack rate of influenza in children (&lt;18 years) varies from year to year, ranging between 10 and 40 percent during a typical influenza season [<a href="#rid1">1,28</a>]. The estimated incidence of symptomatic influenza in children &lt;18 years is approximately 9 percent [<a href="#rid29">29</a>]. Influenza virus infections in children are associated with increased frequency of outpatient visits, hospitalization, antibiotic utilization, missed school days for the patient and patient's siblings, and missed work days for the caregiver(s) [<a href="#rid30">30-33</a>].</p><p>Young children and those with certain underlying medical conditions  (<a class="graphic graphic_table graphicRef72029" href="/z/d/graphic/72029.html" rel="external">table 1</a>) are at increased risk for hospitalization or severe or complicated influenza infection, which also can occur in healthy children [<a href="#rid34">34-39</a>]. (See <a class="local">'Complications'</a> below.)</p><p>The high burden of disease, including preventable mortality, highlights the importance of influenza immunization for all individuals ≥6 months of age (especially contacts of infants &lt;6 months of age) and of initiating antiviral treatment as early as possible for children who are &lt;2 years old, are hospitalized, have severe illness, or have underlying medical conditions  (<a class="graphic graphic_table graphicRef72029" href="/z/d/graphic/72029.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/5960.html" rel="external">"Seasonal influenza in children: Prevention with vaccines", section on 'Target groups'</a> and  <a class="medical medical_review" href="/z/d/html/5985.html" rel="external">"Seasonal influenza in children: Management", section on 'Antiviral therapy'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outpatient visits</strong> – The rate of influenza-related outpatient visits among children in the United States varies from year to year, ranging from 6 to 29 per 100 children [<a href="#rid31">31,40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hospitalization</strong> – The rate of influenza hospitalization is greater in children &lt;5 years than in older children. In population-based surveillance during the influenza seasons from 2010-2011 to 2018-2019, the hospitalization rate was greatest for infants &lt;6 months of age (237 per 100,000); mean hospitalization rates ranged from 55 to 118 per 100,000 for children 6 months through 4 years of age and from 25 to 40 per 100,000 for children age 5 through 17 years [<a href="#rid41">41</a>]. Among the 13,235 children hospitalized, 20 percent were admitted to the intensive care unit and 5 percent required mechanical ventilation.</p><p></p><p class="bulletIndent1">Although influenza virus infection is associated with increased rates of hospitalization in children with high-risk medical conditions  (<a class="graphic graphic_table graphicRef72029" href="/z/d/graphic/72029.html" rel="external">table 1</a>), approximately 50 percent of children hospitalized had no underlying condition [<a href="#rid41">41</a>].</p><p></p><p class="bulletIndent1">The major cause of hospitalization in infants with influenza is an undifferentiated febrile illness, which may require an evaluation for serious bacterial infection because of the acute onset of fever and absence of localizing signs [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/z/d/html/6072.html" rel="external">"The febrile infant (29 to 90 days of age): Outpatient evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/6075.html" rel="external">"Fever without a source in children 3 to 36 months of age: Evaluation and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mortality </strong>– In population-based surveillance in the United States between 2010-2011 and 2018-2019, among 13,325 children &lt;18 years with influenza-related hospitalization, 0.5 percent died during hospitalization [<a href="#rid41">41</a>]. During the 2021-2022 influenza season, 37 pediatric deaths were reported to the CDC [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1">Detailed information about influenza-associated pediatric mortality in the United States is available from the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fgis.cdc.gov%2FGRASP%2FFluview%2FPedFluDeath.html&amp;token=bANOa7JdRXaVgeXHt1aQVOx2nvl9Y790fTKfTfkvoFDDVT02rMWTdzjArYHlo%2BhuXrn%2BIvhusjFNk46HW7RsDg%3D%3D&amp;TOPIC_ID=5973" target="_blank">CDC</a> [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1">Factors associated with increased mortality include [<a href="#rid44">44-46</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Underlying medical problems associated with increased risk of severe or complicated influenza  (<a class="graphic graphic_table graphicRef72029" href="/z/d/graphic/72029.html" rel="external">table 1</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Age &lt;5 years (particularly &lt;2 years, and among those &lt;2 years, particularly those &lt;6 months)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bacterial coinfection with <em>Staphylococcus aureus</em> or <em>Streptococcus pneumoniae</em> [<a href="#rid47">47</a>] (see <a class="local">'S. pneumoniae or S. aureus coinfection'</a> below)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Increased circulation of influenza A H3N2 strains (ie, ≥20 percent of isolates) [<a href="#rid48">48</a>] (see <a class="local">'Influenza activity'</a> above)</p><p></p><p class="bulletIndent1">Although the risk of death is increased among children with high-risk medical conditions, approximately one-half of pediatric influenza deaths occur among children <strong>without</strong> high-risk conditions [<a href="#rid44">44,49,50</a>]. Previously healthy children without high-risk conditions who acquire influenza may be more likely to die before hospital admission and within three days of symptom onset.</p><p></p><p class="bulletIndent1"><strong>Reporting influenza mortality</strong> – Influenza-associated deaths in children (&lt;18 years) should be reported to the CDC through the state health department [<a href="#rid1">1,51</a>]. If the death was complicated by <em>S. aureus</em> infection, the <em>S. aureus</em> isolate should be sent to the CDC.</p><p></p><p class="headingAnchor" id="H1760477089"><span class="h1">UNCOMPLICATED INFLUENZA</span></p><p class="headingAnchor" id="H7"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>The clinical manifestations of influenza virus infection vary with the child's age and previous experience with influenza virus. The classic symptoms of uncomplicated influenza virus infection include abrupt onset of fever, headache, myalgia, and malaise, accompanied by manifestations of respiratory-tract illness, such as cough, sore throat, and rhinitis [<a href="#rid52">52,53</a>]. Symptoms may be less severe in children who develop influenza despite influenza immunization [<a href="#rid54">54</a>].</p><p>Classic features may be absent in children with influenza virus infection. Young children may not be able to vocalize their symptoms; they tend to have higher fevers, febrile seizures, less prominent respiratory findings, and more gastrointestinal complaints (eg, nausea, vomiting, diarrhea, poor appetite) at the time of presentation  (<a class="graphic graphic_table graphicRef50643" href="/z/d/graphic/50643.html" rel="external">table 2</a>) [<a href="#rid52">52,55-58</a>].</p><p>Children with uncomplicated influenza may have few localizing findings; fever and malaise may be the only recognized manifestations [<a href="#rid22">22,59</a>]. When present, localized findings are usually nonspecific and include tachypnea; conjunctival erythema; nasal injection, edema, and discharge; cervical adenopathy; and parotitis [<a href="#rid45">45,60-62</a>]. Oropharyngeal abnormalities other than slight to moderate hyperemia are uncommon, even with complaints of sore throat.</p><p>In a prospective cohort of 353 children (≤13 years) with laboratory-confirmed influenza who were treated as outpatients, clinical features at initial presentation included  (<a class="graphic graphic_table graphicRef50643" href="/z/d/graphic/50643.html" rel="external">table 2</a>) [<a href="#rid52">52</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Fever – 95 percent (50 percent had fever &gt;39°C [102.2°F])</p><p class="bulletIndent1"><span class="glyph">●</span>Cough – 77 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Rhinitis – 78 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Headache – 26 percent (among children 3 to 13 years of age)</p><p class="bulletIndent1"><span class="glyph">●</span>Myalgia – 7 percent (among children 3 to 13 years of age)</p><p></p><p>The spectrum of clinical findings and the severity of infection may vary with the type or subtype of influenza. As examples, influenza B infection is more typically associated with musculoskeletal findings than influenza A [<a href="#rid63">63-66</a>]; 2009 pandemic H1N1 influenza (influenza A[H1N1]pdm09) and influenza A (H3N2) have been associated with more severe illness than other subtypes [<a href="#rid67">67-75</a>]. However, these observations are inconsistent, with some studies reporting no difference in clinical findings associated with influenza types and subtypes, particularly in children &lt;13 years [<a href="#rid52">52,76-79</a>].</p><p>Factors determining the severity of an outbreak are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7006.html" rel="external">"Influenza: Epidemiology and pathogenesis"</a>.)</p><p class="headingAnchor" id="H3592959565"><span class="h2">Clinical course</span><span class="headingEndMark"> — </span>Influenza in otherwise healthy children generally is an acute, self-limited, and uncomplicated disease; however, more severe illness requiring hospitalization and, rarely, death may occur. The risk of complicated or severe influenza infection is increased in children with high-risk conditions  (<a class="graphic graphic_table graphicRef72029" href="/z/d/graphic/72029.html" rel="external">table 1</a>) [<a href="#rid39">39,45,46</a>]. (See <a class="local">'Burden of disease'</a> above and <a class="local">'Complications'</a> below.)</p><p>Patients with uncomplicated influenza usually improve gradually over approximately one week (with or without antiviral therapy) [<a href="#rid77">77</a>], but symptoms – especially cough – may persist, particularly in young children. Weakness and easy fatigability may last for several weeks in older children and are sometimes referred to as "post-influenza asthenia."</p><p>Children who recover from one episode of influenza infection may be infected with a different influenza type or subtype later in the season. In a retrospective review of 647 patients with laboratory-confirmed influenza, 13 children had consecutive influenza A and B infections during a single season [<a href="#rid80">80</a>]. None of the children had received influenza vaccine or antiviral therapy; all of the children presented with typical clinical manifestations of influenza for both episodes. This observation underscores the need to administer influenza vaccine even after the start of the season to protect against other circulating strains.</p><p class="headingAnchor" id="H3578765312"><span class="h2">Laboratory features</span><span class="headingEndMark"> — </span>Leukocyte counts are normal or low early in the illness but may become elevated later in the illness. White blood cell counts &gt;15,000 cells/microL suggest bacterial superinfection [<a href="#rid81">81-83</a>].</p><p class="headingAnchor" id="H9"><span class="h1">COMPLICATIONS</span></p><p class="headingAnchor" id="H3662936754"><span class="h2">Otitis media</span><span class="headingEndMark"> — </span>Otitis media complicates the course of influenza in 10 to 50 percent of children [<a href="#rid30">30,52,84</a>]. The typical time of onset for otitis media is three to four days after the onset of influenza symptoms. (See  <a class="medical medical_review" href="/z/d/html/6021.html" rel="external">"Acute otitis media in children: Epidemiology, microbiology, and complications", section on 'Pathogenesis'</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Pneumonia and respiratory tract complications</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pneumonia</strong> – Pneumonia is a major complication of influenza, particularly in high-risk patients  (<a class="graphic graphic_table graphicRef72029" href="/z/d/graphic/72029.html" rel="external">table 1</a>). In children without underlying high-risk conditions, influenza pneumonia occurs most frequently in children younger than two years [<a href="#rid40">40,81,85</a>]. In population-based surveillance, 28 percent of children hospitalized with influenza during 2003 to 2010 had pneumonia [<a href="#rid86">86</a>].</p><p></p><p class="bulletIndent1">Influenza pneumonia is usually mild and of short duration; however, in hospitalized children, it increases the risk of a severe clinical course [<a href="#rid85">85,86</a>]. Bacterial coinfection with <em>S. aureus</em> or <em>S. pneumoniae</em> may be particularly severe and rapidly fatal. (See <a class="local">'S. pneumoniae or S. aureus coinfection'</a> below.)</p><p></p><p class="bulletIndent1">The radiographic pattern of influenza pneumonia is variable. In a review of 134 cases of radiographically-confirmed influenza pneumonia in children &lt;4 years of age, the infiltrates were interstitial in one-half of cases, alveolar in one-fourth, and interstitial and alveolar in one-fourth [<a href="#rid81">81</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other respiratory complications</strong> – Other respiratory tract complications of influenza infection include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Exacerbation of underlying chronic pulmonary conditions, particularly asthma [<a href="#rid86">86-88</a>] – In population-based surveillance, asthma exacerbation occurred in 22 percent of children &gt;2 years of age who were hospitalized with influenza during 2003 to 2010 [<a href="#rid86">86</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Respiratory failure – In population-based surveillance, respiratory failure occurred in 5 percent of children hospitalized with influenza during 2003 to 2010 [<a href="#rid86">86</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Laryngotracheitis or tracheobronchitis (croup) – Influenza virus laryngotracheitis or tracheobronchitis may be particularly severe or complicated by bacterial superinfection (bacterial tracheitis) [<a href="#rid40">40,86,89,90</a>]. (See  <a class="medical medical_review" href="/z/d/html/6002.html" rel="external">"Croup: Clinical features, evaluation, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6034.html" rel="external">"Bacterial tracheitis in children: Clinical features and diagnosis", section on 'Presentation'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Plastic bronchitis – Plastic bronchitis (thick, inspissated, tracheobronchial casts) is a rarely reported complication of influenza in children [<a href="#rid91">91-95</a>].</p><p></p><p class="headingAnchor" id="H2359997378"><span class="h2">Secondary bacterial infection</span></p><p class="headingAnchor" id="H2033536467"><span class="h3">S. pneumoniae or S. aureus coinfection</span><span class="headingEndMark"> — </span>Secondary bacterial coinfection (eg, pneumonia or bacteremia), most commonly due to <em>S. pneumoniae</em> or<em> S. aureus</em>, may occur in children with or without high-risk conditions and can be particularly severe and rapidly fatal [<a href="#rid47">47,86,96-103</a>]. Bacterial coinfection should be suspected in children with severe influenza/influenza-like illness, children with clinical deterioration after initial improvement, children who fail to improve after three to five days of antiviral therapy, and children with abrupt recrudescence of fever one to two weeks after influenza-like illness [<a href="#rid45">45</a>].</p><p>In population-based surveillance, bacterial coinfection occurred in 2 percent of children hospitalized with influenza during 2003 to 2010 [<a href="#rid86">86</a>]. In a 2016 systematic review of the frequency of influenza and bacterial coinfection, the rate of bacterial coinfection ranged from 2 percent in studies of children seen in mixed settings (emergency department, hospital) to 26 percent in hospitalized children to 50 percent in children hospitalized in the intensive care unit [<a href="#rid101">101</a>]. <em>S. pneumoniae</em> accounted for 35 percent of coinfections, and <em>S. aureus</em> accounted for 28 percent. The risk of pneumococcal pneumonia associated with influenza virus may be reduced by immunization against <em>S. pneumoniae</em>. (See  <a class="medical medical_review" href="/z/d/html/6053.html" rel="external">"Pneumococcal vaccination in children", section on 'Efficacy and effectiveness'</a>.)</p><p>Most cases of severe coinfection with influenza and <em>S. aureus</em> occur in individuals with no previous medical problems. Coinfection with influenza and methicillin-resistant <em>S. aureus </em>(MRSA) appears to be associated with a personal history of methicillin-MRSA skin infection or contact with a person with MRSA skin infection [<a href="#rid98">98</a>]. (See  <a class="medical medical_review" href="/z/d/html/6065.html" rel="external">"Methicillin-resistant <i>Staphylococcus aureus </i>infections in children: Epidemiology and clinical spectrum", section on 'Epidemiology and risk factors'</a>.)</p><p>Toxic shock syndrome, associated with acute influenza and <em>S. aureus</em> infection, has been described after both influenza A and B infections [<a href="#rid104">104-106</a>]. (See  <a class="medical medical_review" href="/z/d/html/3161.html" rel="external">"Staphylococcal toxic shock syndrome", section on 'Clinical manifestations'</a>.)</p><p>Fatal cases of coinfection with influenza and <em>S. aureus</em> in the United States should be reported to the Centers for Disease Control and Prevention (CDC) through the state health department [<a href="#rid1">1</a>]. In such cases, the <em>S. aureus</em> isolate should be sent to the CDC.</p><p class="headingAnchor" id="H1252008716"><span class="h3">Other bacterial coinfections</span><span class="headingEndMark"> — </span>Serious bacterial coinfections of the head and neck (eg, orbital cellulitis, retropharyngeal abscess, peritonsillar abscess, Pott puffy tumor, subdural empyema, septic thrombophlebitis of the internal jugular vein [Lemierre syndrome]) have also been reported in children with influenza infection [<a href="#rid107">107</a>].</p><p class="headingAnchor" id="H1606387483"><span class="h2">Secondary fungal infection</span><span class="headingEndMark"> — </span>Invasive pulmonary aspergillosis has been reported as a complication of influenza in critically ill patients (mostly adults) admitted to the intensive care unit. The frequency of influenza coinfection with invasive aspergillosis varies geographically and by institution [<a href="#rid108">108-112</a>]; the risk is increased in immune-compromised patients undergoing chemotherapy for hematologic malignancies, immune suppression after solid organ transplantation, particularly lung transplant, and treatment for graft versus host disease in allogeneic stem cell transplant recipients.</p><p class="headingAnchor" id="H12"><span class="h2">Central nervous system</span><span class="headingEndMark"> — </span>Central nervous system (CNS) complications occur in approximately 8 to 10 percent of children hospitalized with influenza and 25 percent of children hospitalized with severe influenza [<a href="#rid113">113-117</a>]. CNS complications are associated with increased severity of illness (eg, increased duration of hospitalization, increased rates of intensive care and/or mechanical ventilation, death). Although the risk of CNS complications is increased in children with pre-existing neurologic conditions, most children with CNS complications do not have pre-existing neurologic conditions [<a href="#rid117">117</a>].</p><p>In a cross-sectional study of &gt;29,000 children hospitalized with influenza during 2015 to 2020, 7.6 percent had a neurologic complication [<a href="#rid113">113</a>]. The complications included:</p><p class="bulletIndent1"><span class="glyph">●</span>Febrile seizure in 5 percent of children (53.7 percent of complications)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Encephalopathy in 1.7 percent of children (18.7 percent of complications)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nonfebrile seizure in 1.2 percent of children (13.2 percent of complications)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Encephalitis, aseptic meningitis, brain abscess/bacterial meningitis, cerebral infarction, and Reye syndrome in ≤0.12 percent of children (≤1.3 percent of complications)</p><p></p><p>Other reported CNS complications include acute cerebellar ataxia, transverse myelitis, Guillain-Barré syndrome, and postinfectious encephalitis (also known as acute disseminated encephalomyelitis) [<a href="#rid118">118-120</a>].</p><p class="headingAnchor" id="H13"><span class="h2">Musculoskeletal</span><span class="headingEndMark"> — </span>Acute myositis is a rare and severe complication of influenza [<a href="#rid63">63,121</a>]. The hallmark of acute myositis is extreme tenderness of the affected muscles, most commonly the calves. In severe cases, swelling and bogginess of the muscles may be noted. Serum creatine phosphokinase (CPK) concentrations are markedly elevated, and myoglobinuria with associated renal failure has been reported [<a href="#rid64">64,121</a>]. (See  <a class="medical medical_review" href="/z/d/html/5161.html" rel="external">"Muscle enzymes in the evaluation of neuromuscular diseases", section on 'Infectious myopathies'</a> and  <a class="medical medical_review" href="/z/d/html/5165.html" rel="external">"Overview of viral myositis", section on 'Benign acute childhood myositis'</a>.)</p><p>Mild, transient myositis with mild CPK elevation is more common than classic acute myositis in children with influenza. It is more frequently observed with influenza B than influenza A infections [<a href="#rid63">63-66</a>].</p><p class="headingAnchor" id="H16"><span class="h2">Cardiac</span><span class="headingEndMark"> — </span>Influenza-related myocarditis and pericarditis are uncommon in children but may be severe and fulminant, particularly with influenza A(H1N1)pdm09 virus [<a href="#rid122">122-124</a>]. (See  <a class="medical medical_review" href="/z/d/html/5755.html" rel="external">"Clinical manifestations and diagnosis of myocarditis in children", section on 'Clinical manifestations'</a>.)</p><p class="headingAnchor" id="H17"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H18"><span class="h2">Clinical suspicion</span><span class="headingEndMark"> — </span>During the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprofessionals%2Findex.htm&amp;token=XFqvguR05SOOyL7g%2F321Izvi82Nu2wrgma5G%2FzWtGY7mKV2hHF6d7LbbgqgrDP7dklGfSwkL1RMYuBzFU%2FpKOA%3D%3D&amp;TOPIC_ID=5973" target="_blank">influenza season</a>, influenza virus infection should be considered (regardless of influenza immunization status or previous episode of influenza infection during the current season) in [<a href="#rid45">45,80</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Febrile infants</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children with fever and acute onset of respiratory illness (even if these symptoms develop during hospitalization)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children with fever and exacerbation of underlying chronic pulmonary disease (eg, asthma, cystic fibrosis)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children with community-acquired febrile pneumonia</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children with fever (≥37.8°C [100°F]) and cough, sore throat, or both in the absence of another known cause of illness when influenza virus is known to be circulating in the community</p><p></p><p>Influenza virus infection also should be considered at any time of year in children with febrile respiratory illness who are epidemiologically linked to an outbreak of influenza [<a href="#rid45">45</a>].</p><p>Clinical diagnosis of influenza in children is difficult, particularly in infants and young children [<a href="#rid40">40,125,126</a>]. Other viruses, particularly respiratory syncytial virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and parainfluenza viruses, may cause similar clinical syndromes in children during influenza season [<a href="#rid52">52,127-129</a>]. (See <a class="local">'Differential diagnosis'</a> below.)</p><p>It is usually not necessary to differentiate between influenza and other respiratory viruses. Laboratory confirmation of influenza is not necessary for initiation of antiviral therapy, and supportive care does not differ for influenza and other respiratory viruses. (See  <a class="medical medical_review" href="/z/d/html/5985.html" rel="external">"Seasonal influenza in children: Management"</a>.)</p><p class="headingAnchor" id="H20"><span class="h2">Whom to test</span><span class="headingEndMark"> — </span>Laboratory testing for influenza virus should be performed in patients with clinical features compatible with influenza when the results will affect management (eg, initiation of antibiotic or antiviral therapy, performance of other diagnostic tests, infection control, need for immunization of contacts) [<a href="#rid1">1,45,130</a>].</p><p>Laboratory confirmation is <strong>not</strong> necessary before initiation of antiviral therapy or contact prophylaxis and should not delay initiation of this intervention in individuals for whom it is indicated. (See  <a class="medical medical_review" href="/z/d/html/5985.html" rel="external">"Seasonal influenza in children: Management", section on 'Antiviral therapy'</a>.)</p><p>During the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprofessionals%2Findex.htm&amp;token=XFqvguR05SOOyL7g%2F321Izvi82Nu2wrgma5G%2FzWtGY7mKV2hHF6d7LbbgqgrDP7dklGfSwkL1RMYuBzFU%2FpKOA%3D%3D&amp;TOPIC_ID=5973" target="_blank">influenza season</a>, indications for laboratory testing in children include [<a href="#rid45">45,131</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Suspected influenza in patients with high risk of complications  (<a class="graphic graphic_table graphicRef72029" href="/z/d/graphic/72029.html" rel="external">table 1</a>), including underlying medical conditions and age &lt;2 years</p><p></p><p class="bulletIndent1">Febrile young infants (zero to three months) with a positive rapid diagnostic test for influenza may require additional evaluation. The approach to febrile young infants (zero to three months) with a positive rapid diagnostic test for influenza is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6072.html" rel="external">"The febrile infant (29 to 90 days of age): Outpatient evaluation", section on 'Influenza'</a> and  <a class="medical medical_review" href="/z/d/html/134347.html" rel="external">"The febrile neonate (28 days of age or younger): Outpatient evaluation and initial management", section on 'Diagnosed with viral infections'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hospitalization and acute febrile respiratory illness (even if symptoms develop during hospitalization)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hospitalization and severe respiratory illness, including community-acquired pneumonia</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hospitalization and neurologic complications of influenza (eg, meningitis, encephalitis, encephalopathy)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hospitalization and acute worsening of chronic cardiopulmonary disease (eg, asthma, heart failure)</p><p></p><p>The duration of symptoms may affect testing and treatment decisions. Although antiviral therapy is most effective when it is administered within the first 48 hours of symptom onset, it is indicated beyond 48 hours in severely ill patients and patients with certain underlying medical conditions, such as the immunocompromised. (See <a class="local">'Respiratory specimen collection'</a> below and  <a class="medical medical_review" href="/z/d/html/5985.html" rel="external">"Seasonal influenza in children: Management", section on 'Antiviral therapy'</a>.)</p><p>Our approach to testing for influenza is consistent with that of the American Academy of Pediatrics [<a href="#rid1">1,132</a>], Infectious Diseases Society of America [<a href="#rid45">45</a>], and the Centers for Disease Control and Prevention (CDC) [<a href="#rid133">133</a>].</p><p class="headingAnchor" id="H2172752848"><span class="h2">Approach to testing</span><span class="headingEndMark"> — </span>Laboratory confirmation of influenza virus infection requires detection of viral proteins or viral ribonucleic acid (RNA), or viral isolation, in respiratory-tract secretions or other relevant samples (eg, cerebrospinal fluid). A negative antigen test does not exclude influenza infection. A positive influenza test does not exclude other respiratory pathogens. A positive test for another respiratory pathogen does not exclude influenza. (See <a class="local">'Testing for SARS-CoV-2'</a> below.)</p><p class="headingAnchor" id="H2836639993"><span class="h3">Seasonal influenza</span><span class="headingEndMark"> — </span>The approach to testing for seasonal influenza depends upon test availability and how soon the results are needed  (<a class="graphic graphic_table graphicRef69655" href="/z/d/graphic/69655.html" rel="external">table 3</a>) [<a href="#rid45">45,134</a>]. Laboratory confirmation is not necessary for treatment. For patients at increased risk of severe or complicated influenza (eg, those who are immunocompromised), treatment should be initiated as soon as possible based on clinical findings and local influenza activity. (See  <a class="medical medical_review" href="/z/d/html/5985.html" rel="external">"Seasonal influenza in children: Management", section on 'Indications and preferred regimens'</a>.)</p><p>If available, we prefer molecular assays (eg, reverse-transcriptase polymerase chain reaction [RT-PCR] or rapid molecular assays) to antigen detection tests. Antigen detection tests (eg, direct and indirect immunofluorescence assays, traditional rapid influenza diagnostic tests [RIDTs]) may be used if molecular assays are not available; in hospitalized (symptomatic) patients, negative antigen test results should be confirmed with a molecular assay [<a href="#rid45">45</a>]. Although digital immunoassays (DIAs) appear to have sensitivity approaching that of molecular tests and are commercially available, additional clinical experience is necessary to confirm their utility at the point of care [<a href="#rid135">135,136</a>].</p><p>During the winter respiratory virus season, for hospitalized patients who are immunocompromised, we use a two-step process: PCR for influenza, respiratory syncytial virus (RSV), and SARS-CoV-2, followed by multiplex PCR if influenza, RSV, and SARS-CoV-2 PCR are negative. Other institutions perform multiplex PCR without initial PCR for influenza and RSV.</p><p>Testing for multiple pathogens also may be warranted for hospitalized patients who are not immunocompromised if the results would affect management (eg, antimicrobial therapy, isolation, additional testing) [<a href="#rid45">45</a>]. During the coronavirus disease 2019 (COVID-19) pandemic, children who are hospitalized for influenza generally should be tested for SARS-CoV-2. (See  <a class="medical medical_review" href="/z/d/html/128404.html" rel="external">"COVID-19: Diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Molecular assays</strong> – Molecular assays include RT-PCR assays (singleplex or multiplex) and rapid molecular assays. A summary of available molecular assays for influenza viruses is provided on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprofessionals%2Fdiagnosis%2Fmolecular-assays.htm&amp;token=EZ7dnPGG3Mf%2FpjeAyku2uRC9SjXsO%2F%2B5sLAktCO8Kq7%2FaT89SbqwVTel9vP9ArHlmHl9Vbjqp%2ByJJGUnkCu7mrzc3IgR2gONnGi6%2Fz%2FaEGc%3D&amp;TOPIC_ID=5973" target="_blank">CDC's website</a> [<a href="#rid137">137</a>].</p><p></p><p class="bulletIndent1">Molecular assays that identify influenza viral RNA or proteins in respiratory specimens are preferred to antigen detection methods because molecular assays are more sensitive and specific [<a href="#rid45">45,134,138,139</a>]. Some molecular assays can differentiate between influenza types and subtypes (including pandemic influenza and H5N1 avian influenza)  (<a class="graphic graphic_table graphicRef69655" href="/z/d/graphic/69655.html" rel="external">table 3</a>) [<a href="#rid45">45,140-142</a>]. Identification of viral RNA does not necessarily indicate ongoing viral replication or viable virus [<a href="#rid137">137</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>RT-PCR</strong> – Turn-around time for RT-PCR varies with the assay but typically ranges between one and eight hours [<a href="#rid137">137</a>]. RT-PCR can distinguish between influenza A and B and subtypes of influenza A. Sensitivity ranges between 86 and 100 percent [<a href="#rid1">1</a>]. Availability may be limited in certain settings.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Rapid molecular assays</strong> – Rapid molecular assays provide results in &lt;30 minutes [<a href="#rid143">143</a>]. They can distinguish between influenza A and B (but not subtypes). Rapid molecular assays are more sensitive than antigen-detection RIDTs [<a href="#rid139">139</a>]. Rapid molecular assays are widely available [<a href="#rid144">144</a>].</p><p></p><p class="bulletIndent2">Several rapid molecular assays have been granted a waiver under the Clinical Laboratory Improvement Amendments (CLIA) and are available for use in nontraditional laboratory sites (eg, clinician's offices, emergency departments, health department clinics) [<a href="#rid137">137</a>].</p><p></p><p class="bulletIndent2">In a meta-analysis of 63 studies evaluating rapid molecular assays (results available in &lt;3 hours) for influenza in children and adults, the sensitivity and specificity were 91 percent (95% CI 89-93 percent) and 96 percent (95% CI 94-98 percent), respectively, using RT-PCR as the reference standard [<a href="#rid139">139</a>]. The sensitivity for individual assays ranged from 82 to 99 percent. In subgroup analysis, pooled sensitivity was higher in children than in adults (93 versus 80 percent) and pooled specificity was lower (81 versus 99 percent).</p><p></p><p class="bulletIndent1">It is important to obtain the influenza vaccination history in children who undergo influenza testing with molecular assays. Molecular assays may detect live attenuated vaccine virus strains during the period of viral shedding (which peaks 2 to 3 days after administration but may persist for more than 10 days) [<a href="#rid145">145,146</a>]. (See  <a class="medical medical_review" href="/z/d/html/5960.html" rel="external">"Seasonal influenza in children: Prevention with vaccines", section on 'Adverse effects'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antigen detection assays </strong>–<strong> </strong>Antigen detection assays include direct and indirect immunofluorescence assays, DIAs – also called rapid immunochromatographic antigen detection tests – and traditional RIDTs. A summary of available antigen detection tests for influenza viruses is provided on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprofessionals%2Fdiagnosis%2Ftable-ridt.html&amp;token=7HgiYz7Up6UFIJd8gMcMfyoG3VBlgdfHKWAsVQNnYjiULBuvHHLkFhx0yKiwU%2BRdL3z6Giug0BBPhA%2BwLHM1P4sS8DZmbnLAw7QliZLEVEY%3D&amp;TOPIC_ID=5973" target="_blank">CDC's website</a> [<a href="#rid147">147</a>].</p><p></p><p class="bulletIndent1">Antigen detection assays are an alternative to molecular assays, but because they have lower sensitivity, results must be interpreted with caution, particularly results of direct and indirect immunofluorescence assays and traditional RIDTs [<a href="#rid45">45,148,149</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A negative result when influenza prevalence is high does not exclude influenza and may warrant follow-up RT-PCR or other molecular assay if confirmation is necessary (eg, in hospitalized children)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A positive result when influenza prevalence is low is more likely to be a false positive than a true positive (see  <a class="medical medical_review" href="/z/d/html/2769.html" rel="external">"Evaluating diagnostic tests", section on 'Disease prevalence'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A positive result in a patient with exposure to pigs or poultry may have a novel or variant influenza A virus rather than seasonal influenza virus, even when seasonal influenza prevalence is high (see <a class="local">'Variant influenza viruses'</a> below and  <a class="medical medical_review" href="/z/d/html/7006.html" rel="external">"Influenza: Epidemiology and pathogenesis"</a> and  <a class="medical medical_review" href="/z/d/html/7002.html" rel="external">"Avian influenza: Epidemiology and transmission"</a> and  <a class="medical medical_review" href="/z/d/html/7001.html" rel="external">"Avian influenza: Clinical manifestations and diagnosis"</a>)</p><p></p><p class="bulletIndent1">Three types of antigen detection tests are described below:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Direct and indirect</strong> <strong>immunofluorescence assays </strong>– Direct and indirect immunofluorescence assays provide results in one to four hours [<a href="#rid143">143,150</a>]. They distinguish between influenza types and between influenza and other respiratory viruses. Direct and indirect immunofluorescence assays have moderate sensitivity (ranging from 70 to 100 percent), have high specificity, and generally perform better than antigen detection RIDT  (<a class="graphic graphic_table graphicRef69655" href="/z/d/graphic/69655.html" rel="external">table 3</a>) [<a href="#rid45">45,140,151</a>]. However, their performance depends upon laboratory expertise and the quality of the respiratory specimen. These assays can be used to confirm influenza but not to exclude it.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Digital immunoassays</strong> – DIAs (also called rapid immunochromatographic antigen detection assays) enhance accuracy of immunofluorescence assays by using a digital analyzer, which eliminates the need for a technician to view and interpret the results [<a href="#rid152">152</a>]. DIAs provide results in 10 to 15 minutes [<a href="#rid152">152</a>]. They distinguish between influenza A and B. They are less sensitive than molecular assays but more sensitive than traditional RIDTs [<a href="#rid138">138</a>].</p><p></p><p class="bulletIndent2">Two commercially available rapid immunochromatographic antigen detection tests have been granted a waiver under CLIA [<a href="#rid138">138</a>] and are available for use in nontraditional laboratory sites (eg, clinician's offices, emergency departments, health department clinics).</p><p></p><p class="bulletIndent2">In a meta-analysis analysis of 18 studies of DIA for influenza A and 17 studies of DIA for influenza B in children and adults, the sensitivity was 80 percent (95% CI 73-86 percent) for influenza A and 77 percent (95% CI 65-85 percent) for influenza B; specificity was &gt;98 percent for influenza A and influenza B [<a href="#rid138">138</a>]. In subgroup analysis, sensitivity was greater for children than adults (88 versus 75 percent for influenza A and 83 versus 57 percent for influenza B).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Traditional antigen detection RIDT </strong>– Traditional antigen detection RIDTs provide results in &lt;15 minutes [<a href="#rid143">143,148</a>]. Antigen detection RIDTs include antigen detection (enzyme immunoassay) and neuraminidase detection assays.</p><p></p><p class="bulletIndent2">Antigen detection RIDTs can be used to confirm influenza but not to exclude it [<a href="#rid153">153,154</a>]. Antigen detection RIDTs are less sensitive than molecular assays, direct and indirect immunofluorescence assays, and DIAs [<a href="#rid138">138</a>]. In a person who recently received <a class="drug drug_pediatric" data-topicid="12941" href="/z/d/drug information/12941.html" rel="external">live attenuated influenza vaccine</a>, a positive RIDT result may indicate detection of vaccine virus [<a href="#rid155">155</a>].</p><p></p><p class="bulletIndent2">In a meta-analysis of 94 studies of RIDT for influenza A and 30 studies of RIDT for influenza B in children and adults, the sensitivity was 54 percent (95% CI 49-60 percent) for influenza A and 53 percent (95% CI 42 to 64 percent) for influenza B; specificity was &gt;99 percent for influenza A and influenza B [<a href="#rid138">138</a>]. In subgroup analysis, sensitivity was greater for children than for adults (61 versus 43 percent for influenza A and 66 versus 33 percent for influenza B).</p><p></p><p class="bulletIndent2">The performance of RIDT varies with patient age, duration of illness, sample type, the prevalence of influenza in the community, virus type, and concentration of influenza virus in the sample [<a href="#rid153">153,154,156,157</a>]. Information regarding the sensitivity and specificity of a particular RIDT against the currently circulating strains of influenza may be obtained from local, state, and public health laboratories, or the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprofessionals%2Fdiagnosis%2Findex.htm&amp;token=CaMjlUrgeHxAn9ByNlXc4FAgHVwoTJ%2FRSW6a0H921U9kkCsjSU0nYIT9sCGIRm3WIcMzqj2zsQaEvMfDYPuWsg%3D%3D&amp;TOPIC_ID=5973" target="_blank">CDC</a>.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Viral culture </strong>– Viral culture is not used for initial clinical management because the results are not available for 24 to 72 hours. However, it may be used for public health surveillance (eg, to provide isolates for further characterization).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Serologic testing </strong>– Serologic testing is not helpful in clinical decision-making because diagnosis requires paired acute and convalescent sera. It is useful primarily for research purposes.</p><p></p><p class="headingAnchor" id="H237606676"><span class="h3">Variant influenza viruses</span><span class="headingEndMark"> — </span>Variant influenza virus infection should be suspected in individuals with a febrile respiratory illness who have been exposed to swine or have contacts with close exposure to swine [<a href="#rid158">158-160</a>]. Cases of infection with influenza A(H3N2) variant and influenza A(H1N2) variant virus were reported to the CDC in August 2022 [<a href="#rid159">159</a>]. (See  <a class="medical medical_review" href="/z/d/html/7006.html" rel="external">"Influenza: Epidemiology and pathogenesis", section on 'Role of animals'</a>.)</p><p>Genome sequencing at the CDC can confirm isolates as variant influenza viruses [<a href="#rid158">158,161</a>]. Clinicians who suspect variant influenza virus infection should obtain a nasopharyngeal swab, place it in viral transport media, and contact their state or local health department for testing using real-time RT-PCR [<a href="#rid161">161</a>]. A negative rapid antigen test does not conclusively exclude variant influenza virus infection. The ability of rapid antigen tests to detect variant influenza varies substantially among the available tests. </p><p>Additional information about <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fswineflu%2Fvariant-flu-in-humans.htm&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLJETFjHOKB73VB4sl8d85wRAEu7AE3IrxqsVuFlcLd4gFMqfIreyCRXz476mMg%2FwYA%3D%3D&amp;TOPIC_ID=5973" target="_blank">H3N2v influenza</a> and <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fswineflu%2Findex.htm&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLJETFjHOKB73VB4sl8d85wTffLKlSiFWrTlgrbix5CCr&amp;TOPIC_ID=5973" target="_blank">other variant influenza virus infections</a> is available from the CDC [<a href="#rid160">160,162</a>].</p><p class="headingAnchor" id="H2155324711"><span class="h3">Testing for SARS-CoV-2</span><span class="headingEndMark"> — </span>In areas affected by the SARS-CoV-2 pandemic, children who are tested for influenza generally should also be tested for SARS-CoV-2, which causes COVID-19 [<a href="#rid163">163</a>]. The clinical features of influenza and SARS-CoV-2 overlap, and coinfection or sequential infection with these pathogens may occur. The clinical features and diagnosis of COVID-19 in children are discussed separately (See  <a class="medical medical_review" href="/z/d/html/127488.html" rel="external">"COVID-19: Clinical manifestations and diagnosis in children"</a>.)</p><p class="headingAnchor" id="H1854063348"><span class="h2">Respiratory specimen collection</span><span class="headingEndMark"> — </span>Respiratory specimens should be obtained as soon as possible after illness onset [<a href="#rid1">1</a>]. The likelihood of a positive test is increased when specimens are obtained within 24 to 96 hours of symptoms onset, when the amount of influenza virus in the nasopharynx is at its peak [<a href="#rid153">153</a>]. In immunocompetent older children and adults, there is little viral shedding after five days of illness, and negative tests during this period do not reliably exclude influenza. In infants, young children, and immunocompromised hosts, the duration of viral shedding may exceed one week. (See <a class="local">'Transmission'</a> above.)</p><p>The appropriate specimen (eg, nasopharyngeal wash, aspirate, or swab; throat swab; lower respiratory secretions) depends upon the testing method  (<a class="graphic graphic_table graphicRef69655" href="/z/d/graphic/69655.html" rel="external">table 3</a>). In general, nasopharyngeal specimens, midturbinate nasal swabs, or nasal specimens combined with throat specimens usually are more effective than throat swab specimens alone for viral isolation or rapid detection [<a href="#rid45">45,164</a>]. Midturbinate nasal swabs appear to be acceptable for molecular testing. In a convenience sample of 484 emergency department patients, midturbinate swabs were 98 percent sensitive (95% CI 94-100) but caused less discomfort than the reference standard nasopharyngeal swab [<a href="#rid165">165</a>].</p><p>Specimens for influenza testing should be transported on ice and then refrigerated.</p><p class="headingAnchor" id="H518579446"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of influenza in children includes infection or coinfection with other respiratory viruses, bacterial infections, and noninfectious causes of lower respiratory tract symptoms. Microbiologic testing generally distinguishes influenza from these conditions if differentiation will affect management. (See <a class="local">'Diagnosis'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span>Other respiratory viruses include [<a href="#rid51">51,52,127,128</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>SARS-CoV-2, which causes COVID-19 (see  <a class="medical medical_review" href="/z/d/html/127488.html" rel="external">"COVID-19: Clinical manifestations and diagnosis in children"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Respiratory syncytial virus (see  <a class="medical medical_review" href="/z/d/html/5994.html" rel="external">"Respiratory syncytial virus infection: Clinical features and diagnosis in infants and children", section on 'Clinical manifestations'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Parainfluenza viruses (see  <a class="medical medical_review" href="/z/d/html/5975.html" rel="external">"Parainfluenza viruses in children", section on 'Clinical presentation'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Adenovirus (see  <a class="medical medical_review" href="/z/d/html/8339.html" rel="external">"Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Rhinovirus (see  <a class="medical medical_review" href="/z/d/html/8335.html" rel="external">"Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections", section on 'Clinical illness'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Enteroviruses (see  <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">"Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Clinical features of enterovirus infections'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bacterial causes of clinical syndromes that overlap with influenza include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pneumonia (see  <a class="medical medical_review" href="/z/d/html/5986.html" rel="external">"Community-acquired pneumonia in children: Clinical features and diagnosis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Tonsillopharyngitis (see  <a class="medical medical_review" href="/z/d/html/5971.html" rel="external">"Group A streptococcal tonsillopharyngitis in children and adolescents: Clinical features and diagnosis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Rhinosinusitis (see  <a class="medical medical_review" href="/z/d/html/6069.html" rel="external">"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Noninfectious causes of lower respiratory tract symptoms are discussed separately (see  <a class="medical medical_review" href="/z/d/html/5986.html" rel="external">"Community-acquired pneumonia in children: Clinical features and diagnosis", section on 'Differential diagnosis'</a>)</p><p></p><p class="headingAnchor" id="H2695555710"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/111532.html" rel="external">"Society guideline links: Treatment and prevention of seasonal influenza with antivirals"</a>.)</p><p class="headingAnchor" id="H24"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword[s] of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/3992.html" rel="external">"Patient education: Influenza prevention (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/z/d/html/4010.html" rel="external">"Patient education: Influenza symptoms and treatment (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H25"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology </strong>– Influenza occurs in distinct outbreaks every year, mainly during the winter months. Influenza viruses are spread from person to person, primarily through contact with respiratory secretions or contaminated objects (fomites). The incubation period ranges from one to four days (mean two days). (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1">Young children and children with certain underlying medical conditions are at increased risk for hospitalization or severe or complicated influenza infection  (<a class="graphic graphic_table graphicRef72029" href="/z/d/graphic/72029.html" rel="external">table 1</a>), which also occur in healthy children. Approximately one-half of pediatric influenza deaths occur in previously healthy children. (See <a class="local">'Burden of disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Uncomplicated influenza</strong> – The classic symptoms of uncomplicated influenza virus infection include abrupt onset of fever, headache, myalgia, and malaise, accompanied by manifestations of respiratory-tract illness, such as cough, sore throat, and rhinitis. However, classic features may be absent in children  (<a class="graphic graphic_table graphicRef50643" href="/z/d/graphic/50643.html" rel="external">table 2</a>). Influenza symptoms may last for more than a week, particularly among young children. (See <a class="local">'Uncomplicated influenza'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications</strong> – Common complications of influenza include otitis media, pneumonia, and exacerbation of chronic pulmonary disease (eg, asthma). (See <a class="local">'Complications'</a> above.)</p><p></p><p class="bulletIndent1">Secondary bacterial coinfection (pneumonia or bacteremia), most commonly due <em>to Streptococcus pneumoniae or Staphylococcus aureus</em>, may occur in children with or without high-risk conditions. Pneumonia coinfection with influenza a<em>nd S. pneumoniae</em> <em>or S. aureus</em> may be particularly severe and rapidly fatal. (See <a class="local">'S. pneumoniae or S. aureus coinfection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical suspicion</strong> – During the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprofessionals%2Findex.htm&amp;token=XFqvguR05SOOyL7g%2F321Izvi82Nu2wrgma5G%2FzWtGY7mKV2hHF6d7LbbgqgrDP7dklGfSwkL1RMYuBzFU%2FpKOA%3D%3D&amp;TOPIC_ID=5973" target="_blank">influenza season</a> or a known influenza outbreak, influenza virus infection should be considered (regardless of influenza immunization status or previous episode of influenza infection during the current season) in (see <a class="local">'Clinical suspicion'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Febrile infants</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Children with fever and acute onset of respiratory illness (even if these symptoms develop during hospitalization)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Children with fever and exacerbation of underlying chronic pulmonary disease</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Children with community-acquired febrile pneumonia</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Children with fever (≥37.8°C [100°F]) and cough, sore throat, or both in the absence of another known cause of illness when influenza virus is known to be circulating in the community</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Whom to test</strong> – Laboratory testing for influenza virus should be performed when the results will affect decisions regarding treatment, prophylaxis of contacts, performance of other diagnostic tests, or infection control. Laboratory confirmation should not delay the initiation of antiviral therapy in individuals in whom treatment is indicated. (See <a class="local">'Whom to test'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Laboratory confirmation</strong> – Laboratory confirmation of influenza virus infection requires detection of viral proteins or viral RNA, or viral isolation, in respiratory tract secretions or other samples. The approach to testing depends upon test availability and how soon the results are needed  (<a class="graphic graphic_table graphicRef69655" href="/z/d/graphic/69655.html" rel="external">table 3</a>) (see <a class="local">'Approach to testing'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>If available, we prefer molecular assays (eg, reverse-transcriptase polymerase chain reaction or rapid molecular assays) to antigen detection tests.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Antigen detection tests (eg, direct and indirect immunofluorescence assays, traditional rapid influenza diagnostic tests [RIDTs]) may be used if molecular assays are not available. However, in hospitalized patients, negative antigen immunofluorescence assay and traditional RIDT results should be confirmed with molecular assays.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Although digital immunoassays appear to have sensitivity approaching that of molecular tests and are commercially available, additional clinical experience is necessary to confirm their utility at the point of care.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>During periods of increased influenza activity, patients with negative antigen detection tests also may warrant confirmation with molecular assays or viral culture. (See <a class="local">'Approach to testing'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">American Academy of Pediatrics. Influenza. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.447.</li><li><a class="nounderline abstract_t">Matsuzaki Y, Ikeda T, Abiko C, et al. Detection and quantification of influenza C virus in pediatric respiratory specimens by real-time PCR and comparison with infectious viral counts. J Clin Virol 2012; 54:130.</a></li><li><a class="nounderline abstract_t">Shimizu Y, Abiko C, Ikeda T, et al. Influenza C Virus and Human Metapneumovirus Infections in Hospitalized Children With Lower Respiratory Tract Illness. Pediatr Infect Dis J 2015; 34:1273.</a></li><li><a class="nounderline abstract_t">Principi N, Scala A, Daleno C, Esposito S. Influenza C virus–associated community-acquired pneumonia in children. Influenza Other Respir Viruses 2013; 7:999.</a></li><li><a class="nounderline abstract_t">Matsuzaki Y, Sugawara K, Abiko C, et al. Epidemiological information regarding the periodic epidemics of influenza C virus in Japan (1996-2013) and the seroprevalence of antibodies to different antigenic groups. J Clin Virol 2014; 61:87.</a></li><li><a class="nounderline abstract_t">Calvo C, García-García ML, Borrell B, et al. Prospective study of influenza C in hospitalized children. Pediatr Infect Dis J 2013; 32:916.</a></li><li><a class="nounderline abstract_t">Thielen BK, Friedlander H, Bistodeau S, et al. Detection of Influenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013-2016. Clin Infect Dis 2018; 66:1092.</a></li><li><a class="nounderline abstract_t">Schuster JE, Williams JV. Emerging Respiratory Viruses in Children. Infect Dis Clin North Am 2018; 32:65.</a></li><li><a class="nounderline abstract_t">Fritsch A, Schweiger B, Biere B. Influenza C virus in pre-school children with respiratory infections: retrospective analysis of data from the national influenza surveillance system in Germany, 2012 to 2014. Euro Surveill 2019; 24.</a></li><li><a class="nounderline abstract_t">Global Influenza Programme WEP. Review of the 2019 influenza season in the southern hemisphere. Wkly Epidemiol Rec 2020; 95:1.</a></li><li><a class="nounderline abstract_t">Bischoff WE, Reid T, Russell GB, Peters TR. Transocular entry of seasonal influenza-attenuated virus aerosols and the efficacy of n95 respirators, surgical masks, and eye protection in humans. J Infect Dis 2011; 204:193.</a></li><li class="breakAll">IOM (Institute of Medicine). Preventing Transmission of Pandemic Influenza and Other Viral Respiratory Diseases: Personal Protective Equipment for Healthcare Personnel Update 2010, National Academies Press, Washington, DC 2011.</li><li><a class="nounderline abstract_t">Fong MW, Leung NHL, Xiao J, et al. Presence of Influenza Virus on Touch Surfaces in Kindergartens and Primary Schools. J Infect Dis 2020; 222:1329.</a></li><li><a class="nounderline abstract_t">Bischoff WE, Swett K, Leng I, Peters TR. Exposure to influenza virus aerosols during routine patient care. J Infect Dis 2013; 207:1037.</a></li><li><a class="nounderline abstract_t">Wong BC, Lee N, Li Y, et al. Possible role of aerosol transmission in a hospital outbreak of influenza. Clin Infect Dis 2010; 51:1176.</a></li><li><a class="nounderline abstract_t">Noti JD, Lindsley WG, Blachere FM, et al. Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room. Clin Infect Dis 2012; 54:1569.</a></li><li><a class="nounderline abstract_t">Yan J, Grantham M, Pantelic J, et al. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community. Proc Natl Acad Sci U S A 2018; 115:1081.</a></li><li><a class="nounderline abstract_t">Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362:2175.</a></li><li><a class="nounderline abstract_t">Lau LL, Cowling BJ, Fang VJ, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis 2010; 201:1509.</a></li><li><a class="nounderline abstract_t">Suess T, Buchholz U, Dupke S, et al. Shedding and transmission of novel influenza virus A/H1N1 infection in households--Germany, 2009. Am J Epidemiol 2010; 171:1157.</a></li><li><a class="nounderline abstract_t">Ip DK, Lau LL, Chan KH, et al. The Dynamic Relationship Between Clinical Symptomatology and Viral Shedding in Naturally Acquired Seasonal and Pandemic Influenza Virus Infections. Clin Infect Dis 2016; 62:431.</a></li><li><a class="nounderline abstract_t">Hall CB, Douglas RG Jr. Nosocomial influenza infection as a cause of intercurrent fevers in infants. Pediatrics 1975; 55:673.</a></li><li><a class="nounderline abstract_t">Klimov AI, Rocha E, Hayden FG, et al. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis 1995; 172:1352.</a></li><li><a class="nounderline abstract_t">Frank AL, Taber LH, Wells CR, et al. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis 1981; 144:433.</a></li><li><a class="nounderline abstract_t">Memoli MJ, Athota R, Reed S, et al. The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis 2014; 58:214.</a></li><li><a class="nounderline abstract_t">von Mollendorf C, Hellferscee O, Valley-Omar Z, et al. Influenza Viral Shedding in a Prospective Cohort of HIV-Infected and Uninfected Children and Adults in 2 Provinces of South Africa, 2012-2014. J Infect Dis 2018; 218:1228.</a></li><li><a class="nounderline abstract_t">Loeb M, Singh PK, Fox J, et al. Longitudinal study of influenza molecular viral shedding in Hutterite communities. J Infect Dis 2012; 206:1078.</a></li><li><a class="nounderline abstract_t">Somes MP, Turner RM, Dwyer LJ, Newall AT. Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis. Vaccine 2018; 36:3199.</a></li><li><a class="nounderline abstract_t">Tokars JI, Olsen SJ, Reed C. Seasonal Incidence of Symptomatic Influenza in the United States. Clin Infect Dis 2018; 66:1511.</a></li><li><a class="nounderline abstract_t">Heikkinen T, Silvennoinen H, Peltola V, et al. Burden of influenza in children in the community. J Infect Dis 2004; 190:1369.</a></li><li><a class="nounderline abstract_t">Poehling KA, Edwards KM, Griffin MR, et al. The burden of influenza in young children, 2004-2009. Pediatrics 2013; 131:207.</a></li><li><a class="nounderline abstract_t">Petrie JG, Cheng C, Malosh RE, et al. Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013. Clin Infect Dis 2016; 62:448.</a></li><li><a class="nounderline abstract_t">McLean HQ, Peterson SH, King JP, et al. School absenteeism among school-aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012-2013 through 2014-2015. Influenza Other Respir Viruses 2017; 11:220.</a></li><li><a class="nounderline abstract_t">Burton C, Vaudry W, Moore D, et al. Burden of seasonal influenza in children with neurodevelopmental conditions. Pediatr Infect Dis J 2014; 33:710.</a></li><li><a class="nounderline abstract_t">Chaves SS, Perez A, Farley MM, et al. The burden of influenza hospitalizations in infants from 2003 to 2012, United States. Pediatr Infect Dis J 2014; 33:912.</a></li><li><a class="nounderline abstract_t">Gill PJ, Ashdown HF, Wang K, et al. Identification of children at risk of influenza-related complications in primary and ambulatory care: a systematic review and meta-analysis. Lancet Respir Med 2015; 3:139.</a></li><li><a class="nounderline abstract_t">Hardelid P, Verfuerden M, McMenamin J, Gilbert R. Risk factors for admission to hospital with laboratory-confirmed influenza in young children: birth cohort study. Eur Respir J 2017; 50.</a></li><li><a class="nounderline abstract_t">Blyth CC, Macartney KK, McRae J, et al. Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Children Admitted to Sentinel Australian Hospitals in 2017: Results from the PAEDS-FluCAN Collaboration. Clin Infect Dis 2019; 68:940.</a></li><li><a class="nounderline abstract_t">Tuckerman J, Misan S, Crawford NW, Marshall HS. Influenza in Children With Special Risk Medical Conditions: A Systematic Review and Meta-analysis. Pediatr Infect Dis J 2019; 38:912.</a></li><li><a class="nounderline abstract_t">Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med 2006; 355:31.</a></li><li><a class="nounderline abstract_t">Kamidani S, Garg S, Rolfes MA, et al. Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in US Children Over 9 Seasons Following the 2009 H1N1 Pandemic. Clin Infect Dis 2022; 75:1930.</a></li><li><a class="nounderline abstract_t">Bender JM, Ampofo K, Gesteland P, et al. Influenza virus infection in infants less than three months of age. Pediatr Infect Dis J 2010; 29:6.</a></li><li class="breakAll">CDC. Fluview interactive. Influenza associated pediatric mortality. https://gis.cdc.gov/GRASP/Fluview/PedFluDeath.html (Accessed on September 27, 2022).</li><li><a class="nounderline abstract_t">Shang M, Blanton L, Brammer L, et al. Influenza-Associated Pediatric Deaths in the United States, 2010-2016. Pediatrics 2018; 141.</a></li><li><a class="nounderline abstract_t">Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis 2019; 68:e1.</a></li><li><a class="nounderline abstract_t">Grohskopf LA, Alyanak E, Ferdinands JM, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season. MMWR Recomm Rep 2021; 70:1.</a></li><li><a class="nounderline abstract_t">Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008; 122:805.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010; 59:1057.</a></li><li><a class="nounderline abstract_t">Garten R, Blanton L, Elal AIA, et al. Update: Influenza Activity in the United States During the 2017-18 Season and Composition of the 2018-19 Influenza Vaccine. MMWR Morb Mortal Wkly Rep 2018; 67:634.</a></li><li><a class="nounderline abstract_t">Blanton L, Dugan VG, Abd Elal AI, et al. Update: Influenza Activity - United States, September 30, 2018-February 2, 2019. MMWR Morb Mortal Wkly Rep 2019; 68:125.</a></li><li><a class="nounderline abstract_t">Fowlkes A, Giorgi A, Erdman D, et al. Viruses associated with acute respiratory infections and influenza-like illness among outpatients from the Influenza Incidence Surveillance Project, 2010-2011. J Infect Dis 2014; 209:1715.</a></li><li><a class="nounderline abstract_t">Silvennoinen H, Peltola V, Lehtinen P, et al. Clinical presentation of influenza in unselected children treated as outpatients. Pediatr Infect Dis J 2009; 28:372.</a></li><li><a class="nounderline abstract_t">Uyeki TM, Hui DS, Zambon M, et al. Influenza. Lancet 2022; 400:693.</a></li><li><a class="nounderline abstract_t">Danier J, Rivera L, Claeys C, et al. Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine. Pediatr Infect Dis J 2019; 38:866.</a></li><li><a class="nounderline abstract_t">Neuzil KM, Zhu Y, Griffin MR, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 2002; 185:147.</a></li><li><a class="nounderline abstract_t">Peltola V, Ziegler T, Ruuskanen O. Influenza A and B virus infections in children. Clin Infect Dis 2003; 36:299.</a></li><li><a class="nounderline abstract_t">Chiu SS, Tse CY, Lau YL, Peiris M. Influenza A infection is an important cause of febrile seizures. Pediatrics 2001; 108:E63.</a></li><li><a class="nounderline abstract_t">Wang YH, Huang YC, Chang LY, et al. Clinical characteristics of children with influenza A virus infection requiring hospitalization. J Microbiol Immunol Infect 2003; 36:111.</a></li><li><a class="nounderline abstract_t">Dagan R, Hall CB. Influenza A virus infection imitating bacterial sepsis in early infancy. Pediatr Infect Dis 1984; 3:218.</a></li><li class="breakAll">McCullers JA. Influenza viruses. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 8th ed, Cherry JD, Harrison G, Kaplan SL, et al (Eds), Elsevier, Philadelphia 2018. p.1729.</li><li><a class="nounderline abstract_t">Elbadawi LI, Talley P, Rolfes MA, et al. Non-mumps Viral Parotitis During the 2014-2015 Influenza Season in the United States. Clin Infect Dis 2018; 67:493.</a></li><li><a class="nounderline abstract_t">Rolfes MA, Millman AJ, Talley P, et al. Influenza-Associated Parotitis During the 2014-2015 Influenza Season in the United States. Clin Infect Dis 2018; 67:485.</a></li><li><a class="nounderline abstract_t">Hu JJ, Kao CL, Lee PI, et al. Clinical features of influenza A and B in children and association with myositis. J Microbiol Immunol Infect 2004; 37:95.</a></li><li><a class="nounderline abstract_t">Hall CB, Douglas RG Jr, Geiman JM, Meagher MP. Viral shedding patterns of children with influenza B infection. J Infect Dis 1979; 140:610.</a></li><li><a class="nounderline abstract_t">Chi CY, Wang SM, Lin CC, et al. Clinical features of children infected with different strains of influenza B in southern Taiwan. Pediatr Infect Dis J 2008; 27:640.</a></li><li><a class="nounderline abstract_t">Mall S, Buchholz U, Tibussek D, et al. A large outbreak of influenza B-associated benign acute childhood myositis in Germany, 2007/2008. Pediatr Infect Dis J 2011; 30:e142.</a></li><li><a class="nounderline abstract_t">Paules C, Subbarao K. Influenza. Lancet 2017; 390:697.</a></li><li><a class="nounderline abstract_t">Jules A, Grijalva CG, Zhu Y, et al. Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011. Pediatrics 2015; 135:e66.</a></li><li><a class="nounderline abstract_t">Louie JK, Gavali S, Acosta M, et al. Children hospitalized with 2009 novel influenza A(H1N1) in California. Arch Pediatr Adolesc Med 2010; 164:1023.</a></li><li><a class="nounderline abstract_t">Yung M, Slater A, Festa M, et al. Pandemic H1N1 in children requiring intensive care in Australia and New Zealand during winter 2009. Pediatrics 2011; 127:e156.</a></li><li><a class="nounderline abstract_t">Ekstrand JJ, Herbener A, Rawlings J, et al. Heightened neurologic complications in children with pandemic H1N1 influenza. Ann Neurol 2010; 68:762.</a></li><li><a class="nounderline abstract_t">Noah MA, Peek GJ, Finney SJ, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 2011; 306:1659.</a></li><li><a class="nounderline abstract_t">Bagdure D, Curtis DJ, Dobyns E, et al. Hospitalized children with 2009 pandemic influenza A (H1N1): comparison to seasonal influenza and risk factors for admission to the ICU. PLoS One 2010; 5:e15173.</a></li><li><a class="nounderline abstract_t">Chaves SS, Aragon D, Bennett N, et al. Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype. J Infect Dis 2013; 208:1305.</a></li><li><a class="nounderline abstract_t">Rao S, Martin J, Ahearn MA, et al. Neurologic Manifestations of Influenza A(H3N2) Infection in Children During the 2016-2017 Season. J Pediatric Infect Dis Soc 2020; 9:71.</a></li><li><a class="nounderline abstract_t">Silvennoinen H, Huusko T, Vuorinen T, Heikkinen T. Comparative Burden of Influenza A/H1N1, A/H3N2 and B Infections in Children Treated as Outpatients. Pediatr Infect Dis J 2015; 34:1081.</a></li><li><a class="nounderline abstract_t">Cohen JM, Silva ML, Caini S, et al. Striking Similarities in the Presentation and Duration of Illness of Influenza A and B in the Community: A Study Based on Sentinel Surveillance Networks in France and Turkey, 2010-2012. PLoS One 2015; 10:e0139431.</a></li><li><a class="nounderline abstract_t">Mosnier A, Caini S, Daviaud I, et al. Clinical Characteristics Are Similar across Type A and B Influenza Virus Infections. PLoS One 2015; 10:e0136186.</a></li><li><a class="nounderline abstract_t">Mattila JM, Vuorinen T, Heikkinen T. Comparative Severity of Influenza A and B Infections in Hospitalized Children. Pediatr Infect Dis J 2020; 39:489.</a></li><li><a class="nounderline abstract_t">Möst J, Weiss G. Consecutive Infections With Influenza A and B Virus in Children During the 2014-2015 Seasonal Influenza Epidemic. J Infect Dis 2016; 214:1139.</a></li><li><a class="nounderline abstract_t">Lahti E, Peltola V, Virkki R, Ruuskanen O. Influenza pneumonia. Pediatr Infect Dis J 2006; 25:160.</a></li><li><a class="nounderline abstract_t">Lorenzi OD, Gregory CJ, Santiago LM, et al. Acute febrile illness surveillance in a tertiary hospital emergency department: comparison of influenza and dengue virus infections. Am J Trop Med Hyg 2013; 88:472.</a></li><li><a class="nounderline abstract_t">Peltola V, Mertsola J, Ruuskanen O. Comparison of total white blood cell count and serum C-reactive protein levels in confirmed bacterial and viral infections. J Pediatr 2006; 149:721.</a></li><li><a class="nounderline abstract_t">Henderson FW, Collier AM, Sanyal MA, et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med 1982; 306:1377.</a></li><li><a class="nounderline abstract_t">Dawood FS, Fiore A, Kamimoto L, et al. Influenza-associated pneumonia in children hospitalized with laboratory-confirmed influenza, 2003-2008. Pediatr Infect Dis J 2010; 29:585.</a></li><li><a class="nounderline abstract_t">Dawood FS, Chaves SS, Pérez A, et al. Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010. J Infect Dis 2014; 209:686.</a></li><li><a class="nounderline abstract_t">Neuzil KM, Wright PF, Mitchel EF Jr, Griffin MR. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 2000; 137:856.</a></li><li><a class="nounderline abstract_t">Miller EK, Griffin MR, Edwards KM, et al. Influenza burden for children with asthma. Pediatrics 2008; 121:1.</a></li><li><a class="nounderline abstract_t">Rihkanen H, Rönkkö E, Nieminen T, et al. Respiratory viruses in laryngeal croup of young children. J Pediatr 2008; 152:661.</a></li><li><a class="nounderline abstract_t">Peltola V, Heikkinen T, Ruuskanen O. Clinical courses of croup caused by influenza and parainfluenza viruses. Pediatr Infect Dis J 2002; 21:76.</a></li><li><a class="nounderline abstract_t">Nogan SJ, Cass ND, Wiet GJ, Ruda JM. Plastic bronchitis arising from solitary influenza B infection: A report of two cases in children. Int J Pediatr Otorhinolaryngol 2015; 79:1140.</a></li><li><a class="nounderline abstract_t">Zhang J, Kang X. Plastic bronchitis associated with influenza virus infection in children: a report on 14 cases. Int J Pediatr Otorhinolaryngol 2015; 79:481.</a></li><li><a class="nounderline abstract_t">Terano C, Miura M, Fukuzawa R, et al. Three children with plastic bronchitis associated with 2009 H1N1 influenza virus infection. Pediatr Infect Dis J 2011; 30:80.</a></li><li><a class="nounderline abstract_t">Deng J, Zheng Y, Li C, et al. Plastic bronchitis in three children associated with 2009 influenza A(H1N1) virus infection. Chest 2010; 138:1486.</a></li><li><a class="nounderline abstract_t">Zhang X, Vinturache A, Ding G. Plastic bronchitis in a 3-year-old boy. CMAJ 2019; 191:E1336.</a></li><li><a class="nounderline abstract_t">Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006; 12:894.</a></li><li><a class="nounderline abstract_t">Ampofo K, Bender J, Sheng X, et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 2008; 122:229.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007; 56:325.</a></li><li><a class="nounderline abstract_t">Reed C, Kallen AJ, Patton M, et al. Infection with community-onset Staphylococcus aureus and influenza virus in hospitalized children. Pediatr Infect Dis J 2009; 28:572.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1071.</a></li><li><a class="nounderline abstract_t">Klein EY, Monteforte B, Gupta A, et al. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses 2016; 10:394.</a></li><li><a class="nounderline abstract_t">Nguyen T, Kyle UG, Jaimon N, et al. Coinfection with Staphylococcus aureus increases risk of severe coagulopathy in critically ill children with influenza A (H1N1) virus infection. Crit Care Med 2012; 40:3246.</a></li><li><a class="nounderline abstract_t">McDanel JS, Perencevich EN, Storm J, et al. Increased Mortality Rates Associated with Staphylococcus aureus and Influenza Co-infection, Maryland and Iowa, USA(1). Emerg Infect Dis 2016; 22:1253.</a></li><li><a class="nounderline abstract_t">Tolan RW Jr. Toxic shock syndrome complicating influenza A in a child: case report and review. Clin Infect Dis 1993; 17:43.</a></li><li><a class="nounderline abstract_t">Sion ML, Hatzitolios AI, Toulis EN, et al. Toxic shock syndrome complicating influenza A infection: a two-case report with one case of bacteremia and endocarditis. Intensive Care Med 2001; 27:443.</a></li><li><a class="nounderline abstract_t">Prechter GC, Gerhard AK. Postinfluenza toxic shock syndrome. Chest 1989; 95:1153.</a></li><li><a class="nounderline abstract_t">Foster CE, Kaplan SL. Complicated Head and Neck Infections Following Influenza Virus Infection in Children. Pediatr Infect Dis J 2019; 38:e226.</a></li><li><a class="nounderline abstract_t">Verweij PE, Brüggemann RJM, Wauters J, et al. Influenza Coinfection: Be(a)ware of Invasive Aspergillosis. Clin Infect Dis 2020; 70:349.</a></li><li><a class="nounderline abstract_t">Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med 2018; 6:782.</a></li><li><a class="nounderline abstract_t">Schwartz IS, Friedman DZP, Zapernick L, et al. High Rates of Influenza-Associated Invasive Pulmonary Aspergillosis May Not Be Universal: A Retrospective Cohort Study from Alberta, Canada. Clin Infect Dis 2020; 71:1760.</a></li><li><a class="nounderline abstract_t">Rijnders BJA, Schauwvlieghe AFAD, Wauters J. Influenza-Associated Pulmonary Aspergillosis: A Local or Global Lethal Combination? Clin Infect Dis 2020; 71:1764.</a></li><li><a class="nounderline abstract_t">Toda M, Benedict K, Jackson BR. Invasive Aspergillosis After Influenza and Other Viral Respiratory Infections Among Intensive Care Unit Patients in a Commercially Insured Population in the United States, 2013-2018. Open Forum Infect Dis 2021; 8:ofab091.</a></li><li><a class="nounderline abstract_t">Antoon JW, Hall M, Herndon A, et al. Prevalence, Risk Factors, and Outcomes of Influenza-Associated Neurologic Complications in Children. J Pediatr 2021; 239:32.</a></li><li><a class="nounderline abstract_t">Choi GJ, Park JY, Choi JS, et al. Influenza-associated Neurologic Complications in Hospitalized Pediatric Patients: A Multicenter Retrospective Study in Republic of Korea. Pediatr Infect Dis J 2021; 40:e466.</a></li><li><a class="nounderline abstract_t">Frankl S, Coffin SE, Harrison JB, et al. Influenza-Associated Neurologic Complications in Hospitalized Children. J Pediatr 2021; 239:24.</a></li><li><a class="nounderline abstract_t">Solís-García G, Chacón-Pascual A, González Martínez F, et al. Neurologic Complications in Children Hospitalized With Influenza Infections: Prevalence, Risk Factors and Impact on Disease Severity. Pediatr Infect Dis J 2020; 39:789.</a></li><li><a class="nounderline abstract_t">Donnelley E, Teutsch S, Zurynski Y, et al. Severe Influenza-Associated Neurological Disease in Australian Children: Seasonal Population-Based Surveillance 2008-2018. J Pediatric Infect Dis Soc 2022; 11:533.</a></li><li><a class="nounderline abstract_t">Newland JG, Laurich VM, Rosenquist AW, et al. Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr 2007; 150:306.</a></li><li><a class="nounderline abstract_t">Britton PN, Blyth CC, Macartney K, et al. The Spectrum and Burden of Influenza-Associated Neurological Disease in Children: Combined Encephalitis and Influenza Sentinel Site Surveillance from Australia 2013-2015. Clin Infect Dis 2017.</a></li><li><a class="nounderline abstract_t">Vellozzi C, Iqbal S, Broder K. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis 2014; 58:1149.</a></li><li><a class="nounderline abstract_t">Agyeman P, Duppenthaler A, Heininger U, Aebi C. Influenza-associated myositis in children. Infection 2004; 32:199.</a></li><li><a class="nounderline abstract_t">Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med 2010; 38:e91.</a></li><li><a class="nounderline abstract_t">Kumar K, Guirgis M, Zieroth S, et al. Influenza myocarditis and myositis: case presentation and review of the literature. Can J Cardiol 2011; 27:514.</a></li><li><a class="nounderline abstract_t">Bratincsák A, El-Said HG, Bradley JS, et al. Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children. J Am Coll Cardiol 2010; 55:928.</a></li><li><a class="nounderline abstract_t">Peltola V, Reunanen T, Ziegler T, et al. Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis 2005; 41:1198.</a></li><li><a class="nounderline abstract_t">Tapiainen T, Aittoniemi J, Immonen J, et al. Finnish guidelines for the treatment of laryngitis, wheezing bronchitis and bronchiolitis in children. Acta Paediatr 2016; 105:44.</a></li><li><a class="nounderline abstract_t">Babcock HM, Merz LR, Dubberke ER, Fraser VJ. Case-control study of clinical features of influenza in hospitalized patients. Infect Control Hosp Epidemiol 2008; 29:921.</a></li><li><a class="nounderline abstract_t">van den Dool C, Hak E, Wallinga J, et al. Symptoms of influenza virus infection in hospitalized patients. Infect Control Hosp Epidemiol 2008; 29:314.</a></li><li><a class="nounderline abstract_t">Taylor S, Lopez P, Weckx L, et al. Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. J Infect 2017; 74:29.</a></li><li><a class="nounderline abstract_t">Lee JJ, Verbakel JY, Goyder CR, et al. The Clinical Utility of Point-of-Care Tests for Influenza in Ambulatory Care: A Systematic Review and Meta-analysis. Clin Infect Dis 2019; 69:24.</a></li><li><a class="nounderline abstract_t">Gill PJ, Richardson SE, Ostrow O, Friedman JN. Testing for Respiratory Viruses in Children: To Swab or Not to Swab. JAMA Pediatr 2017; 171:798.</a></li><li><a class="nounderline abstract_t">COMMITTEE ON INFECTIOUS DISEASES. Recommendations for Prevention and Control of Influenza in Children, 2022-2023. Pediatrics 2022; 150.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Information for clinicians on influenza virus testing http://www.cdc.gov/flu/professionals/diagnosis/index.htm (Accessed on September 07, 2022).</li><li><a class="nounderline abstract_t">Miller JM, Binnicker MJ, Campbell S, et al. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 2018; 67:e1.</a></li><li><a class="nounderline abstract_t">Ison MG. Contemporary Influenza Diagnostics: Renewed Focus on Testing Patients. Ann Intern Med 2017; 167:438.</a></li><li><a class="nounderline abstract_t">Fekete T. Review: In suspected influenza, some rapid tests have high sensitivity and high specificity for detecting infection. Ann Intern Med 2018; 168:JC9.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Information on rapid molecular assays, RT-PCR, and other molecular assays for diagnosis of influenza virus infection. Available at: https://www.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm (Accessed on September 07, 2022).</li><li><a class="nounderline abstract_t">Merckx J, Wali R, Schiller I, et al. Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction: A Systematic Review and Meta-analysis. Ann Intern Med 2017; 167:394.</a></li><li><a class="nounderline abstract_t">Vos LM, Bruning AHL, Reitsma JB, et al. Rapid Molecular Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review of Diagnostic Accuracy and Clinical Impact Studies. Clin Infect Dis 2019; 69:1243.</a></li><li><a class="nounderline abstract_t">Ginocchio CC, Zhang F, Manji R, et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009; 45:191.</a></li><li><a class="nounderline abstract_t">Daum LT, Canas LC, Schadler CA, et al. A rapid, single-step multiplex reverse transcription-PCR assay for the detection of human H1N1, H3N2, and B influenza viruses. J Clin Virol 2002; 25:345.</a></li><li class="breakAll">New CDC-developed diagnostic lab test for flu approved. http://www.cdc.gov/media/releases/2011/p0902_diag_lab.html?s_cid=2011_p0902_diag_lab.htm (Accessed on August 17, 2016).</li><li><a class="nounderline abstract_t">COMMITTEE ON INFECTIOUS DISEASES. Recommendations for Prevention and Control of Influenza in Children, 2021-2022. Pediatrics 2021; 148.</a></li><li><a class="nounderline abstract_t">Kitt E, Drew RJ, Cunney R, et al. Diagnosis and Management of Pediatric Influenza in the Era of Rapid Diagnostics. J Pediatric Infect Dis Soc 2020; 9:51.</a></li><li><a class="nounderline abstract_t">Lumley S, Atkinson C, Haque T. Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination. Arch Dis Child 2014; 99:301.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Influenza: Information on rapid molecular assays, RT-PCR, and other molecular assays for diagnosis of influenza virus infection. Available at: https://www.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm (Accessed on September 07, 2022).</li><li class="breakAll">Centers for Disease Control and Prevention. Influenza (flu). Rapid influenza diagnostic tests (RIDTs). Available at https://www.cdc.gov/flu/professionals/diagnosis/table-ridt.html (Accessed on September 07, 2022).</li><li class="breakAll">Centers for Disease Control and Prevention. Information for clinicians on rapid diagnostic testing for influenza. http://www.cdc.gov/flu/professionals/diagnosis/rapidclin.htm (Accessed on September 01, 2020).</li><li class="breakAll">Centers for Disease Control and Prevention. Rapid influenza diagnostic tests. https://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm (Accessed on September 01, 2020).</li><li class="breakAll">Centers for Disease Control and Prevention. Overview of influenza testing methods. https://www.cdc.gov/flu/professionals/diagnosis/overview-testing-methods.htm (Accessed on September 30, 2020).</li><li><a class="nounderline abstract_t">Uyeki TM. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J 2003; 22:164.</a></li><li><a class="nounderline abstract_t">Dunn JJ, Ginocchio CC. Can newly developed, rapid immunochromatographic antigen detection tests be reliably used for the laboratory diagnosis of influenza virus infections? J Clin Microbiol 2015; 53:1790.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention. Evaluation of 11 commercially available rapid influenza diagnostic tests--United States, 2011-2012. MMWR Morb Mortal Wkly Rep 2012; 61:873.</a></li><li><a class="nounderline abstract_t">Chartrand C, Leeflang MM, Minion J, et al. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med 2012; 156:500.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Influenza: Rapid influenza diagnostic tests. Available at: https://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm (Accessed on September 07, 2022).</li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Performance of rapid influenza diagnostic tests during two school outbreaks of 2009 pandemic influenza A (H1N1) virus infection - Connecticut, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1029.</a></li><li><a class="nounderline abstract_t">Cruz AT, Cazacu AC, Greer JM, Demmler GJ. Rapid assays for the diagnosis of influenza A and B viruses in patients evaluated at a large tertiary care children's hospital during two consecutive winter seasons. J Clin Virol 2008; 41:143.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011. MMWR Morb Mortal Wkly Rep 2012; 60:1741.</a></li><li class="breakAll">Centers for Disease Control and Prevention (CDC). Health Alert Network. Variant influenza virus infections: Recommendations for identification, treatment, and prevention for summer and fall 2022. https://emergency.cdc.gov/han/2022/han00473.asp (Accessed on September 07, 2022).</li><li class="breakAll">Centers for Disease Control and Prevention. Information on swine/variant influenza. https://www.cdc.gov/flu/swineflu/index.htm (Accessed on September 07, 2022).</li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Evaluation of rapid influenza diagnostic tests for influenza A (H3N2)v virus and updated case count--United States, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:619.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Interim information for clinicians about human infections with H3N2v virus. Available at: https://www.cdc.gov/flu/swineflu/variant/h3n2v-clinician.htm (Accessed on September 07, 2022).</li><li class="breakAll">American Academy of Pediatrics. Critical Updates on COVID-19. COVID-19 Interim Guidance. COVID-19 Testing Guidance. https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/covid-19-testing-guidance/ (Accessed on January 12, 2023).</li><li><a class="nounderline abstract_t">Robinson JL, Lee BE, Kothapalli S, et al. Use of throat swab or saliva specimens for detection of respiratory viruses in children. Clin Infect Dis 2008; 46:e61.</a></li><li><a class="nounderline abstract_t">Frazee BW, Rodríguez-Hoces de la Guardia A, Alter H, et al. Accuracy and Discomfort of Different Types of Intranasal Specimen Collection Methods for Molecular Influenza Testing in Emergency Department Patients. Ann Emerg Med 2018; 71:509.</a></li></ol></div><div id="topicVersionRevision">Topic 5973 Version 83.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : American Academy of Pediatrics. Influenza. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.447.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22398038" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Detection and quantification of influenza C virus in pediatric respiratory specimens by real-time PCR and comparison with infectious viral counts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26244834" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Influenza C Virus and Human Metapneumovirus Infections in Hospitalized Children With Lower Respiratory Tract Illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23594251" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Influenza C virus–associated community-acquired pneumonia in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25017953" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Epidemiological information regarding the periodic epidemics of influenza C virus in Japan (1996-2013) and the seroprevalence of antibodies to different antigenic groups.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23624431" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Prospective study of influenza C in hospitalized children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29069373" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Detection of Influenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29406977" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Emerging Respiratory Viruses in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30862333" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Influenza C virus in pre-school children with respiratory infections: retrospective analysis of data from the national influenza surveillance system in Germany, 2012 to 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Review of the 2019 influenza season in the southern hemisphere</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21673029" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Transocular entry of seasonal influenza-attenuated virus aerosols and the efficacy of n95 respirators, surgical masks, and eye protection in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21673029" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Transocular entry of seasonal influenza-attenuated virus aerosols and the efficacy of n95 respirators, surgical masks, and eye protection in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32179916" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Presence of Influenza Virus on Touch Surfaces in Kindergartens and Primary Schools.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23372182" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Exposure to influenza virus aerosols during routine patient care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20942655" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Possible role of aerosol transmission in a hospital outbreak of influenza.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22460981" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29348203" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20558368" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Comparative epidemiology of pandemic and seasonal influenza A in households.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20377412" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Viral shedding and clinical illness in naturally acquired influenza virus infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20439308" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Shedding and transmission of novel influenza virus A/H1N1 infection in households--Germany, 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26518469" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The Dynamic Relationship Between Clinical Symptomatology and Viral Shedding in Naturally Acquired Seasonal and Pandemic Influenza Virus Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1168894" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Nosocomial influenza infection as a cause of intercurrent fevers in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7594676" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6273473" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Patterns of shedding of myxoviruses and paramyxoviruses in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24186906" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29800425" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Influenza Viral Shedding in a Prospective Cohort of HIV-Infected and Uninfected Children and Adults in 2 Provinces of South Africa, 2012-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22837493" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Longitudinal study of influenza molecular viral shedding in Hutterite communities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29716771" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29206909" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Seasonal Incidence of Symptomatic Influenza in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15378427" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Burden of influenza in children in the community.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23296444" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The burden of influenza in young children, 2004-2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26565004" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27885805" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : School absenteeism among school-aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012-2013 through 2014-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24918745" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Burden of seasonal influenza in children with neurodevelopmental conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24577042" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The burden of influenza hospitalizations in infants from 2003 to 2012, United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25481379" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Identification of children at risk of influenza-related complications in primary and ambulatory care: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28954782" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Risk factors for admission to hospital with laboratory-confirmed influenza in young children: birth cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30137244" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Children Admitted to Sentinel Australian Hospitals in 2017: Results from the PAEDS-FluCAN Collaboration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31274833" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Influenza in Children With Special Risk Medical Conditions: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16822994" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The underrecognized burden of influenza in young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35438769" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in US Children Over 9 Seasons Following the 2009 H1N1 Pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19915513" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Influenza virus infection in infants less than three months of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19915513" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Influenza virus infection in infants less than three months of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29440502" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Influenza-Associated Pediatric Deaths in the United States, 2010-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30566567" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34448800" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18829805" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20798667" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Estimates of deaths associated with seasonal influenza --- United States, 1976-2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29879098" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Update: Influenza Activity in the United States During the 2017-18 Season and Composition of the 2018-19 Influenza Vaccine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30763296" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Update: Influenza Activity - United States, September 30, 2018-February 2, 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24338352" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Viruses associated with acute respiratory infections and influenza-like illness among outpatients from the Influenza Incidence Surveillance Project, 2010-2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19295464" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Clinical presentation of influenza in unselected children treated as outpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36030813" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Influenza.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31306399" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11807687" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12539071" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Influenza A and B virus infections in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11581471" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Influenza A infection is an important cause of febrile seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12886962" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Clinical characteristics of children with influenza A virus infection requiring hospitalization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6377255" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Influenza A virus infection imitating bacterial sepsis in early infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6377255" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Influenza A virus infection imitating bacterial sepsis in early infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29617951" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Non-mumps Viral Parotitis During the 2014-2015 Influenza Season in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29617957" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Influenza-Associated Parotitis During the 2014-2015 Influenza Season in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15181490" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Clinical features of influenza A and B in children and association with myositis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/512419" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Viral shedding patterns of children with influenza B infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18520968" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Clinical features of children infected with different strains of influenza B in southern Taiwan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21753259" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : A large outbreak of influenza B-associated benign acute childhood myositis in Germany, 2007/2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28302313" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Influenza.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25489015" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21041595" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Children hospitalized with 2009 novel influenza A(H1N1) in California.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21172991" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Pandemic H1N1 in children requiring intensive care in Australia and New Zealand during winter 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20865762" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Heightened neurologic complications in children with pandemic H1N1 influenza.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21976615" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21179517" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Hospitalized children with 2009 pandemic influenza A (H1N1): comparison to seasonal influenza and risk factors for admission to the ICU.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23863950" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30590598" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Neurologic Manifestations of Influenza A(H3N2) Infection in Children During the 2016-2017 Season.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26181897" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Comparative Burden of Influenza A/H1N1, A/H3N2 and B Infections in Children Treated as Outpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26426119" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Striking Similarities in the Presentation and Duration of Illness of Influenza A and B in the Community: A Study Based on Sentinel Surveillance Networks in France and Turkey, 2010-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26325069" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Clinical Characteristics Are Similar across Type A and B Influenza Virus Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32091502" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Comparative Severity of Influenza A and B Infections in Hospitalized Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27095422" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Consecutive Infections With Influenza A and B Virus in Children During the 2014-2015 Seasonal Influenza Epidemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16462295" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Influenza pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23382160" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Acute febrile illness surveillance in a tertiary hospital emergency department: comparison of influenza and dengue virus infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17095353" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Comparison of total white blood cell count and serum C-reactive protein levels in confirmed bacterial and viral infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6281639" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20589966" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Influenza-associated pneumonia in children hospitalized with laboratory-confirmed influenza, 2003-2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23986545" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11113844" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : The burden of influenza illness in children with asthma and other chronic medical conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18166550" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Influenza burden for children with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18410770" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Respiratory viruses in laryngeal croup of young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11791108" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Clinical courses of croup caused by influenza and parainfluenza viruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25957780" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Plastic bronchitis arising from solitary influenza B infection: A report of two cases in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25639552" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Plastic bronchitis associated with influenza virus infection in children: a report on 14 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20686435" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Three children with plastic bronchitis associated with 2009 H1N1 influenza virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21138885" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Plastic bronchitis in three children associated with 2009 influenza A(H1N1) virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31791968" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Plastic bronchitis in a 3-year-old boy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16707043" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18676537" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17431376" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19478685" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Infection with community-onset Staphylococcus aureus and influenza virus in hospitalized children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19798021" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27232677" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22971587" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Coinfection with Staphylococcus aureus increases risk of severe coagulopathy in critically ill children with influenza A (H1N1) virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27315549" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Increased Mortality Rates Associated with Staphylococcus aureus and Influenza Co-infection, Maryland and Iowa, USA(1).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8353244" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Toxic shock syndrome complicating influenza A in a child: case report and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11396292" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Toxic shock syndrome complicating influenza A infection: a two-case report with one case of bacteremia and endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2651040" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Postinfluenza toxic shock syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30747830" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Complicated Head and Neck Infections Following Influenza Virus Infection in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31077266" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Influenza Coinfection: Be(a)ware of Invasive Aspergillosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30076119" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31905235" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : High Rates of Influenza-Associated Invasive Pulmonary Aspergillosis May Not Be Universal: A Retrospective Cohort Study from Alberta, Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31905234" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Influenza-Associated Pulmonary Aspergillosis: A Local or Global Lethal Combination?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33796602" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Invasive Aspergillosis After Influenza and Other Viral Respiratory Infections Among Intensive Care Unit Patients in a Commercially Insured Population in the United States, 2013-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34216629" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Prevalence, Risk Factors, and Outcomes of Influenza-Associated Neurologic Complications in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34609108" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Influenza-associated Neurologic Complications in Hospitalized Pediatric Patients: A Multicenter Retrospective Study in Republic of Korea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34293371" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Influenza-Associated Neurologic Complications in Hospitalized Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32282657" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Neurologic Complications in Children Hospitalized With Influenza Infections: Prevalence, Risk Factors and Impact on Disease Severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36153667" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Severe Influenza-Associated Neurological Disease in Australian Children: Seasonal Population-Based Surveillance 2008-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17307552" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28460008" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : The Spectrum and Burden of Influenza-Associated Neurological Disease in Children: Combined Encephalitis and Influenza Sentinel Site Surveillance from Australia 2013-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24415636" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15293074" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Influenza-associated myositis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19935413" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Complications of seasonal and pandemic influenza.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21652168" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Influenza myocarditis and myositis: case presentation and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20153131" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16163640" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Accuracy of clinical diagnosis of influenza in outpatient children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26295564" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Finnish guidelines for the treatment of laryngitis, wheezing bronchitis and bronchiolitis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18754739" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Case-control study of clinical features of influenza in hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18462143" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Symptoms of influenza virus infection in hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27667752" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30285232" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : The Clinical Utility of Point-of-Care Tests for Influenza in Ambulatory Care: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28672402" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Testing for Respiratory Viruses in Children: To Swab or Not to Swab.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36065750" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Recommendations for Prevention and Control of Influenza in Children, 2022-2023.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36065750" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Recommendations for Prevention and Control of Influenza in Children, 2022-2023.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29955859" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28869977" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Contemporary Influenza Diagnostics: Renewed Focus on Testing Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29335721" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Review: In suspected influenza, some rapid tests have high sensitivity and high specificity for detecting infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29335721" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Review: In suspected influenza, some rapid tests have high sensitivity and high specificity for detecting infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28869986" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30689772" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Rapid Molecular Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review of Diagnostic Accuracy and Clinical Impact Studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19540158" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12423698" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : A rapid, single-step multiplex reverse transcription-PCR assay for the detection of human H1N1, H3N2, and B influenza viruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12423698" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : A rapid, single-step multiplex reverse transcription-PCR assay for the detection of human H1N1, H3N2, and B influenza viruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34493538" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Recommendations for Prevention and Control of Influenza in Children, 2021-2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30476135" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Diagnosis and Management of Pediatric Influenza in the Era of Rapid Diagnostics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24273099" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24273099" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24273099" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24273099" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24273099" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24273099" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12586981" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25274999" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Can newly developed, rapid immunochromatographic antigen detection tests be reliably used for the laboratory diagnosis of influenza virus infections?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23114254" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Evaluation of 11 commercially available rapid influenza diagnostic tests--United States, 2011-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22371850" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Accuracy of rapid influenza diagnostic tests: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22371850" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Accuracy of rapid influenza diagnostic tests: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19779397" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Performance of rapid influenza diagnostic tests during two school outbreaks of 2009 pandemic influenza A (H1N1) virus infection - Connecticut, 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18083627" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Rapid assays for the diagnosis of influenza A and B viruses in patients evaluated at a large tertiary care children's hospital during two consecutive winter seasons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22217624" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22217624" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22217624" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22895386" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : Evaluation of rapid influenza diagnostic tests for influenza A (H3N2)v virus and updated case count--United States, 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22895386" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : Evaluation of rapid influenza diagnostic tests for influenza A (H3N2)v virus and updated case count--United States, 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22895386" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : Evaluation of rapid influenza diagnostic tests for influenza A (H3N2)v virus and updated case count--United States, 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18444806" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Use of throat swab or saliva specimens for detection of respiratory viruses in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29174837" id="rid164" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>165 : Accuracy and Discomfort of Different Types of Intranasal Specimen Collection Methods for Molecular Influenza Testing in Emergency Department Patients.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
